These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 25141979)

  • 61. Polyphenols and AGEs/RAGE axis. Trends and challenges.
    González I; Morales MA; Rojas A
    Food Res Int; 2020 Mar; 129():108843. PubMed ID: 32036875
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Glycation exacerbates the neuronal toxicity of β-amyloid.
    Li XH; Du LL; Cheng XS; Jiang X; Zhang Y; Lv BL; Liu R; Wang JZ; Zhou XW
    Cell Death Dis; 2013 Jun; 4(6):e673. PubMed ID: 23764854
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
    Coskuner-Weber O; Uversky VN
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Understanding the role of glycation in the pathology of various non-communicable diseases along with novel therapeutic strategies.
    Bangar NS; Gvalani A; Ahmad S; Khan MS; Tupe RS
    Glycobiology; 2022 Nov; 32(12):1068-1088. PubMed ID: 36074518
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders II: Alzheimer's disease.
    da Rocha MD; Viegas FP; Campos HC; Nicastro PC; Fossaluzza PC; Fraga CA; Barreiro EJ; Viegas C
    CNS Neurol Disord Drug Targets; 2011 Mar; 10(2):251-70. PubMed ID: 20874701
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.
    Lauterbach EC; Victoroff J; Coburn KL; Shillcutt SD; Doonan SM; Mendez MF
    J Neuropsychiatry Clin Neurosci; 2010; 22(1):8-18. PubMed ID: 20160205
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review.
    Almeida-Santos AF; Kangussu LM; Campagnole-Santos MJ
    Protein Pept Lett; 2017 Nov; 24(9):841-853. PubMed ID: 28828974
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies.
    Kirkitadze MD; Bitan G; Teplow DB
    J Neurosci Res; 2002 Sep; 69(5):567-77. PubMed ID: 12210822
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.
    Takeuchi M; Yamagishi S
    Curr Pharm Des; 2008; 14(10):973-8. PubMed ID: 18473848
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics.
    Schalkwijk CG; Miyata T
    Amino Acids; 2012 Apr; 42(4):1193-204. PubMed ID: 20960212
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hypoxia driven glycation: Mechanisms and therapeutic opportunities.
    Khan MI; Rath S; Adhami VM; Mukhtar H
    Semin Cancer Biol; 2018 Apr; 49():75-82. PubMed ID: 28546110
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ginsenoside derivatives inhibit advanced glycation end-product formation and glucose-fructose mediated protein glycation in vitro via a specific structure-activity relationship.
    Yousof Ali M; Jannat S; Mizanur Rahman M
    Bioorg Chem; 2021 Jun; 111():104844. PubMed ID: 33798848
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An immunochemical study on tau glycation in paired helical filaments.
    Ko LW; Ko EC; Nacharaju P; Liu WK; Chang E; Kenessey A; Yen SH
    Brain Res; 1999 Jun; 830(2):301-13. PubMed ID: 10366687
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative Diseases.
    Rahman MH; Akter R; Kamal MA
    CNS Neurol Disord Drug Targets; 2021; 20(8):694-703. PubMed ID: 32703143
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Preserving Brain Function in Aging: The Anti-glycative Potential of Berry Fruit.
    Thangthaeng N; Poulose SM; Miller MG; Shukitt-Hale B
    Neuromolecular Med; 2016 Sep; 18(3):465-73. PubMed ID: 27166828
    [TBL] [Abstract][Full Text] [Related]  

  • 77. General Aggregation-Induced Emission Probes for Amyloid Inhibitors with Dual Inhibition Capacity against Amyloid β-Protein and α-Synuclein.
    Jia L; Wang W; Yan Y; Hu R; Sang J; Zhao W; Wang Y; Wei W; Cui W; Yang G; Lu F; Zheng J; Liu F
    ACS Appl Mater Interfaces; 2020 Jul; 12(28):31182-31194. PubMed ID: 32584021
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Increased protein glycation in cerebrospinal fluid of Alzheimer's disease.
    Shuvaev VV; Laffont I; Serot JM; Fujii J; Taniguchi N; Siest G
    Neurobiol Aging; 2001; 22(3):397-402. PubMed ID: 11378244
    [TBL] [Abstract][Full Text] [Related]  

  • 79. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.
    Prasad K
    Mol Cell Biochem; 2019 Sep; 459(1-2):95-112. PubMed ID: 31079281
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.
    Salahuddin P; Fatima MT; Abdelhameed AS; Nusrat S; Khan RH
    Eur J Med Chem; 2016 May; 114():41-58. PubMed ID: 26974374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.